Assar Gabrielsson award for effective treatment of cancer4/27/17
Cancer develops by stepwise changes in growth characteristics of the cells that may be caused by genetic and epigenetic changes and environmental factors. With the use of new molecular biological methods the analyses of the biological mechanisms behind cancer development have started and generated new important knowledge.
Joydeep Bhadury has in this thesis presented important translational cancer research that provides a better understanding of how genetic changes are related to the initiation and development of cancer.
“The results of this research can contribute to identify new targets for future effective treatments of various cancer types”, says Professor Eva Forssell-Aronsson, executive member of the Assar Gabrielsson Foundation.
Assar Gabrielsson was one of the founders of Volvo. In accordance with his wishes, a foundation to provide funding for clinical research into cancer diseases was created in 1962. It primarily supports research projects which are considered to be promising but which do not yet have the necessary weight to attract grants from central funds.
The Assar Gabrielsson Award will be presented Thursday May 18 between 12.30 and 14.00 in the Birgit Thilander room at the Academicum at Sahlgrenska Academy, Gothenburg. During the ceremony the award winner will present his research. The ceremony will be held in English.
Journalists who would like further information, please contact:
Eva Forssell-Aronsson, Professor of Radiation Physics and Executive member of the Assar Gabrielsson Foundation phone: +46 703722626
Urban Wass, senior vice president, Research & Innovation policy, Volvo Group and Chair of the Assar Gabrielsson Foundation phone: +46 739028661
For more stories from the Volvo Group, please visit www.volvogroup.com/press.